Table 6 Quality of life, sexual impairment and scar quality 4–6 months after infection, in relation to bacterial superinfections or abscesses during the acute phase

Dermatology Life Quality Index (DLQI)

N

17

9

8

Median (Q1– Q3)

1.0

(0–2.5)

2.0

(1.0–5.5)

0.0

(0.0–1.0)

0.036

Min– Max

0–13

0–13

0–8

General impairment within the last two weeks (scale 0–10)

N

19

9

10

Median (Q1– Q3)

0.0

(0–2)

1.0

(0.0–4.0)

0.0

(0.0–0.5)

0.143

Min– Max

0–6

0–6

0–5

Sexual impairment within the last two weeks (scale 0–10)

N

19

9

10

Median (Q1– Q3)

0.0

(0–5)

5.0

(0.5–7.5)

0.0

(0.0–0.8)

0.017

Min– Max

0–10

0–10

0–7

Pain within the last two weeks (scale 0–10)

N

17

9

8

Median (Q1– Q3)

0.0

(0–0)

0.0

(0.0–0.0)

0.0

(0.0–0.0)

0.864

Min– Max

0–3

0–1

0–3

Visible scarring (n = 19)

Scars present

16

(84.2)

8

(88.9)

8

(80.0)

> 0.999²

Observer Scar Assessment Scale (OSAS)

N

16

8

8

Median (Q1– Q3)

13.5

(9.3–19.8)

18.5

(12.3–22.8)

11.0

(9.0–13.8)

0.059

Min– Max

7–26

7–26

8–19

Patient Scar Assessment Scale (PSAS)

N

14

7

7

Median (Q1– Q3)

14.0

(9.8–27)

24.0

(14.0–34.0)

11.0

(9.0–14.0)

0.039

Min– Max

6–45

10–45

6–27